Abbreviation | Formula | Mass | Main Class | Sub Class |
---|---|---|---|---|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 | C58H107NO21 | 1153.733566 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 | C60H111NO21 | 1181.764866 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 | C62H115NO21 | 1209.796166 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C60H110N2O23 | 1226.749944 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 | C64H119NO21 | 1237.827466 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C62H114N2O23 | 1254.781245 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 | C66H121NO21 | 1263.843116 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 | C66H123NO21 | 1265.858766 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2 | C64H118N2O23 | 1282.812545 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:2;O2 | C68H125NO21 | 1291.874416 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:1;O2 | C68H127NO21 | 1293.890066 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2 | C66H122N2O23 | 1310.843845 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2 | C68H124N2O23 | 1336.859495 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2 | C68H126N2O23 | 1338.875145 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2 | C70H128N2O23 | 1364.890795 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2 | C70H130N2O23 | 1366.906445 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C68H124N2O28 | 1416.834070 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 | C68H123N3O28 | 1429.829318 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C68H123N3O28 | 1429.829318 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2 | C70H128N2O28 | 1444.865370 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 | C70H127N3O28 | 1457.860618 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C70H127N3O28 | 1457.860618 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2 | C72H132N2O28 | 1472.896670 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 | C72H131N3O28 | 1485.891919 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2 | C72H131N3O28 | 1485.891919 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2 | C74H134N2O28 | 1498.912320 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2 | C74H136N2O28 | 1500.927970 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 | C74H135N3O28 | 1513.923219 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2 | C74H135N3O28 | 1513.923219 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2 | C76H138N2O28 | 1526.943620 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2 | C76H140N2O28 | 1528.959270 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 | C76H137N3O28 | 1539.938869 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2 | C76H137N3O28 | 1539.938869 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 | C76H139N3O28 | 1541.954519 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2 | C76H139N3O28 | 1541.954519 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:2;O2 | C78H141N3O28 | 1567.970169 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2 | C78H141N3O28 | 1567.970169 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:1;O2 | C78H143N3O28 | 1569.985819 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2 | C78H143N3O28 | 1569.985819 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C74H133N3O33 | 1591.882144 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C74H133N3O33 | 1591.882144 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C76H137N3O33 | 1619.913444 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C76H137N3O33 | 1619.913444 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2 | C76H136N4O33 | 1632.908692 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2 | C78H141N3O33 | 1647.944744 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2 | C78H141N3O33 | 1647.944744 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2 | C78H140N4O33 | 1660.939992 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2 | C80H145N3O33 | 1675.976044 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2 | C80H145N3O33 | 1675.976044 | Neutral glycosphingolipids [SP05] | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] |